Skip to main content

Articles

Multiple Myeloma, Oncology

ASCO 2017: Multiple Myeloma Highlights

Novel Drug “Home Run” for TRK Mutation–Positive Tumors

Maintenance Treatment in Mantle-Cell Lymphoma Extends Survival

Immunotherapy, Oncology

Adoptive T-Cell Therapy: Ready for Prime Time

Less Is More: Low-Risk Stage III Colon Cancer Safely Treated with Only 3 Months of Adjuvant Chemotherapy

Practice Management

Oncologists Must Begin to Discuss Financial Toxicity with Patients

Original Research, Practice Management

Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients

Suela Sulo, PhD; Josh Feldstein, BA; Jamie Partridge, PhD, MBA; Bjoern Schwander, MS, RN; Krishnan Sriram, MD; Wm. Thomas Summerfelt, PhD

Stakeholder Perspective

The Crucial Role of Nutrition Support Services for Hospitalized Patients

Jack E. Fincham, PhD, RPh

First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas

First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults

FDA Approvals, In the News

Rituximab Combination Now Approved in 3 Blood Cancers

Page 84 of 244
Results 831 - 840 of 2434